Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3868663 | 0.91 | BTK (0.60) | BTKCLK2 | |
| SCHEMBL108327 | 0.86 | BTK (0.81) | BTKCLK2 | |
| SCHEMBL3865855 | 0.86 | BTK (0.62) | BTKCLK2 | |
| SCHEMBL3874826 | 0.86 | BTK (0.64) | BTKCLK2 | |
| SCHEMBL3870913 | 0.77 | BTK (0.51) | BTKCLK2 | |
| SCHEMBL3866591 | 0.77 | BTK (0.51) | BTKCLK2 | |
| SCHEMBL3867475 | 0.77 | BTK (0.51) | BTKCLK2 | |
| SCHEMBL3866595 | 0.77 | BTK (0.51) | BTKCLK2 | |
| SCHEMBL104216 | 0.76 | BTK (1.00) | BTKCLK2 | |
| SCHEMBL13894050 | 0.75 | BTK (0.41) | BTKCLK2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20090105209-A1 | BTK protein kinase inhibitors | ROCHE PALO ALTO LLC | 2009-04-23 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090105209-A1 | BTK protein kinase inhibitors | BTK, SYK, LYN | BTK 1/4885CLK2 552/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.